Stay updated on Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.

Latest updates to the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and the earlier Revision: v3.4.1 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check14 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center operating status has been added, and the site revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedGlossary visibility was added. QC-related metadata was updated, No FEAR Act Data text was introduced, and the revision/version was bumped from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check35 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page reorganizes the Locations section: a general 'Locations' heading is added with state-level entries (California, Florida, Georgia, Kentucky, Maryland, Michigan, Minnesota, Montana, Ohio) and Rozzano. The previous per-state 'Locations' headings are removed, and the Revision tag updates from v3.3.2 to v3.3.3.SummaryDifference0.8%

- Check78 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.